282 related articles for article (PubMed ID: 12436367)
1. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
3. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic alterations in liver cirrhosis.
La Villa G; Gentilini P
Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
[TBL] [Abstract][Full Text] [Related]
6. Conservation of whole body nitric oxide metabolism in human alcoholic liver disease: implications for nitric oxide production.
Demoncheaux EA; Elphick DA; Dürner MB; Higgins GE; Crowther D; Williams EJ; Higenbottam TW; Gleeson D
Scand J Gastroenterol; 2006 Jul; 41(7):820-5. PubMed ID: 16785195
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
8. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S
Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide in patients with chronic liver diseases.
Pârvu AE; Negrean V; Pleşca-Manea L; Cosma A; Drăghici A; Uifălean A; Moldovan R
Rom J Gastroenterol; 2005 Sep; 14(3):225-30. PubMed ID: 16200231
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and renal functions in liver cirrhosis.
Türkay C; Yönem O; Arikan O; Baskin E
Turk J Gastroenterol; 2004 Jun; 15(2):73-6. PubMed ID: 15334313
[TBL] [Abstract][Full Text] [Related]
11. [The role of interleukin-6 and nitric oxide in pathogenesis of portal hypertension and decompensation of liver cirrhosis].
Mirodzhov GK; Avezov SA; Giiasov MM; Abdullaeva ZM
Klin Med (Mosk); 2012; 90(1):47-9. PubMed ID: 22567940
[TBL] [Abstract][Full Text] [Related]
12. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
13. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.
Genesca J; Segura R; Gonzalez A; Catalan R; Marti R; Torregrosa M; Cereto F; Martinez M; Esteban R; Guardia J
Am J Gastroenterol; 2000 Jun; 95(6):1539-44. PubMed ID: 10894593
[TBL] [Abstract][Full Text] [Related]
15. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis.
Hori N; Okanoue T; Mori T; Kashima K; Nishimura M; Nanbu A; Yoshimura M; Takahashi H
Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):30-5. PubMed ID: 8713493
[TBL] [Abstract][Full Text] [Related]
16. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
El-Newihi HM; Kanji VK; Mihas AA
Am J Gastroenterol; 1996 Mar; 91(3):535-8. PubMed ID: 8633504
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
Michielsen PP; Pelckmans PA
Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
[TBL] [Abstract][Full Text] [Related]
18. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Cariello R; Federico A; Sapone A; Tuccillo C; Scialdone VR; Tiso A; Miranda A; Portincasa P; Carbonara V; Palasciano G; Martorelli L; Esposito P; Cartenì M; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2010 Mar; 42(3):200-4. PubMed ID: 19502117
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.
Fernando B; Marley R; Holt S; Anand R; Harry D; Sanderson P; Smith R; Hamilton G; Moore K
Hepatology; 1998 Sep; 28(3):689-94. PubMed ID: 9731560
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
